Completed PHASE2/PHASE3 INTERVENTIONAL 3-arm NCT00413257

Effects of Nefopam on Hyperalgesia After Cardiac Surgery (NefalCard)

Study of the Effects of Nefopam on Hyperalgesia Following Sternotomy in Cardiac Surgery

Sponsor: University Hospital, Bordeaux

Conditions Hyperalgesia Pain, Chronic Disease Pain, Postoperative

Interventions Nefopam Placebo comparator néfopam

Updated 5 times since 2017 Last updated: May 27, 2010 Started: Dec 31, 2006 Primary completion: Dec 31, 2007 Completion: Nov 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Hyperalgesia and Pain, Chronic Disease, this trial is completed. The trial is conducted by University Hospital, Bordeaux and has accumulated 5 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

Dec 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Bordeaux

Data source: University Hospital, Bordeaux

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pessac, France